December 20, 2012 US researchers develop compound to reverse effects of fatty liver disease

US researchers develop compound to reverse effects of fatty liver disease

December 20, 2012
Science Daily

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.

The compound -- known as SR9238 -- is the first to effectively suppress lipid or fat production in the liver, eliminating inflammation and reversing fat accumulation in animal models of fatty liver disease. The new compound also significantly lowered total cholesterol levels, although precisely how that occurred remains something of a mystery.

To read full article, click here.

To learn more about fatty liver disease, click here.

VOLUNTEER
DONATE NOW
YOUR STORY